vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
16.49
+0.33 (2.04%)
Jul 18, 2025, 4:00 PM - Market closed
vTv Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts that cover vTv Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $35.5, which forecasts a 115.28% increase in the stock price over the next year. The lowest target is $35 and the highest is $36.
Price Target: $35.5 (+115.28%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 9, 2025.
Analyst Ratings
The average analyst rating for vTv Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +118.31% | Apr 9, 2025 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +112.25% | Dec 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $240 | Strong Buy | Reiterates | $240 | +1,355.43% | Mar 7, 2023 |
| Northland Capital Markets | Northland Capital Markets | Buy Maintains $60 → $80 | Buy | Maintains | $60 → $80 | +385.14% | Aug 17, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $200 | Buy | Initiates | $200 | +1,112.86% | Feb 18, 2022 |
Financial Forecast
Revenue This Year
n/a
from 1.02M
Revenue Next Year
n/a
EPS This Year
-3.64
from -3.20
EPS Next Year
-3.71
from -3.64
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.75 | -3.55 | -3.51 | ||
| Avg | -3.64 | -3.71 | -3.87 | ||
| Low | -3.50 | -3.82 | -4.17 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.